ATLANTA--(BUSINESS WIRE)--Sciele Pharma, Inc. (NASDAQ:SCRX):
First quarter 2007 financial results include:
Revenues were $82.3 million, an increase of 24% over first quarter of 2006
Diluted earnings per share were $0.36, an increase of 57% over first quarter of 2006
EBITDAS(a), a non-GAAP measure, was $28.6 million, an increase of 31% over first quarter 2006
Cash flow per share(b), a non-GAAP measure, was $0.54, an increase of 50% over first quarter 2006
